| Primary |
| Attention Deficit/hyperactivity Disorder |
53.4% |
| Product Used For Unknown Indication |
12.6% |
| Drug Use For Unknown Indication |
9.4% |
| Disturbance In Attention |
4.5% |
| Aggression |
2.7% |
| Drug Abuse |
2.7% |
| Drug Therapy |
1.3% |
| Emotional Distress |
1.3% |
| Hypothyroidism |
1.3% |
| Initial Insomnia |
1.3% |
| Substance Use |
1.3% |
| Adhd |
0.9% |
| Arthropod Sting |
0.9% |
| Conduct Disorder |
0.9% |
| Depression |
0.9% |
| Major Depression |
0.9% |
| Migraine |
0.9% |
| Narcolepsy |
0.9% |
| Somnolence |
0.9% |
| Suicide Attempt |
0.9% |
|
| Sudden Death |
15.9% |
| Weight Decreased |
9.5% |
| Off Label Use |
6.3% |
| Tachycardia |
6.3% |
| Vomiting |
6.3% |
| Death |
4.8% |
| Depression |
4.8% |
| Product Substitution Issue |
4.8% |
| Pulmonary Embolism |
4.8% |
| Suicide Attempt |
4.8% |
| Cardio-respiratory Arrest |
3.2% |
| Drug Abuse |
3.2% |
| Fatigue |
3.2% |
| Gynaecomastia |
3.2% |
| Intentional Drug Misuse |
3.2% |
| Intentional Overdose |
3.2% |
| Neutropenia |
3.2% |
| Self Injurious Behaviour |
3.2% |
| Serotonin Syndrome |
3.2% |
| Sinus Tachycardia |
3.2% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
73.4% |
| Arthropod Sting |
5.9% |
| Product Used For Unknown Indication |
4.8% |
| Drug Use For Unknown Indication |
2.8% |
| Colon Cancer |
2.2% |
| Cardiovascular Event Prophylaxis |
0.9% |
| Emotional Distress |
0.9% |
| Narcolepsy |
0.9% |
| Psychotherapy |
0.9% |
| Substance Use |
0.9% |
| Complex Partial Seizures |
0.6% |
| Conduct Disorder |
0.6% |
| Coronary Artery Disease |
0.6% |
| Decreased Activity |
0.6% |
| Depression |
0.6% |
| Dyslipidaemia |
0.6% |
| Hypertension |
0.6% |
| Hypothyroidism |
0.6% |
| Perioperative Analgesia |
0.6% |
| Weight Increased |
0.6% |
|
| Psychotic Disorder |
29.2% |
| Off Label Use |
6.2% |
| Withdrawal Syndrome |
6.2% |
| Adverse Event |
4.6% |
| Depression |
4.6% |
| Suicide Attempt |
4.6% |
| Vomiting |
4.6% |
| Cardiac Failure |
3.1% |
| Death |
3.1% |
| Drug Abuse |
3.1% |
| Dyskinesia |
3.1% |
| Grand Mal Convulsion |
3.1% |
| Gynaecomastia |
3.1% |
| Psychomotor Hyperactivity |
3.1% |
| Pulmonary Embolism |
3.1% |
| Respiratory Arrest |
3.1% |
| Splenomegaly |
3.1% |
| Tic |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Tremor |
3.1% |
|
| Concomitant |
| Cataplexy |
14.2% |
| Narcolepsy |
14.2% |
| Attention Deficit/hyperactivity Disorder |
11.0% |
| Depression |
7.1% |
| Somnolence |
6.3% |
| Bipolar Disorder |
5.5% |
| Routine Health Maintenance |
5.5% |
| Prophylaxis |
3.9% |
| Endometriosis |
3.1% |
| Gastrointestinal Stromal Tumour |
3.1% |
| Hyperlipidaemia |
3.1% |
| Hypertension |
3.1% |
| Parkinson's Disease |
3.1% |
| Anxiety |
2.4% |
| Contraception |
2.4% |
| Hypersomnia |
2.4% |
| Insomnia |
2.4% |
| Pain |
2.4% |
| Postoperative Care |
2.4% |
| Product Used For Unknown Indication |
2.4% |
|
| Tricuspid Valve Incompetence |
9.3% |
| Palpitations |
7.0% |
| Restlessness |
7.0% |
| Vomiting |
7.0% |
| Weight Decreased |
7.0% |
| Weight Increased |
7.0% |
| Circulatory Collapse |
4.7% |
| Hypertension |
4.7% |
| Hypoxia |
4.7% |
| Off Label Use |
4.7% |
| Pneumonia |
4.7% |
| Pulmonary Embolism |
4.7% |
| Somnolence |
4.7% |
| Strabismus |
4.7% |
| Tachyphrenia |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Balance Disorder |
2.3% |
| Blood Pressure Increased |
2.3% |
| Brain Neoplasm |
2.3% |
| Device Expulsion |
2.3% |
|
